USPTO serial 79298272
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical agents affecting metabolism; vitamin and mineral preparations for medical use; crude medicines, namely, medicines for the treatment and prevention of atopic skin disease, obesity, digestive disorders, and immune system related diseases and disorders; anti-inflammatory and antipyretic preparations; cardiovascular pharmaceutical preparations; dietetic food supplements; food for babies; preparations of microorganisms for medical or veterinary use; medical and surgical plasters; pharmaceutical and veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; pharmaceutical and veterinary preparations for treating allergic rhinitis and asthma; pharmaceutical and veterinary preparations for ocular and intraocular surgery; pharmaceutical and veterinary preparations acting on the central nervous system; pharmaceutical and veterinary preparations for the prevention of osteoporosis; pharmaceutical and veterinary preparations for use in urology; pharmaceutical and veterinary preparations, namely, drug delivery systems comprising polymer-based oral tablets for the continuous release of therapeutic agents; pharmaceutical and veterinary preparations for use in the anesthesia; pharmaceutical and veterinary preparations for diagnostic purposes; pharmaceutical and veterinary preparations for the peripheral nervous system; pharmaceutical and veterinary preparations for digestive organs; pharmaceutical and veterinary preparations for anti-fungal treatment; nutraceutical preparations for therapeutic or medical purposes; antibiotics; anti-cancer preparations; pharmaceutical preparations for respiratory organs; all aforementioned goods sold only to hospitals or other healthcare institutions and to pharmaceutical companies | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 12, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 21, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 20, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 28, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 30, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 14, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 14, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 14, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 14, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 26, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 26, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 26, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 11, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 3, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 3, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 3, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 1, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 5, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 5, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 22, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 21, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 19, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 24, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 20, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 19, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |